One correlative study of effector T cells derived from CML patients experiencing effective GVL after DLI demonstrated enhanced interferon gamma production from CD8 effector T cells, including cytotoxic T cells specific to patient-derived mhAgs (221). This evidence concerns the gene CD8A and chronic myelogenous leukemia, BCR-ABL1 positive.